Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses.
Larkin RM, Lopez DC, Robbins YL, Lassoued W, Canubas K, Warner A, Karim B, Vulikh K, Hodge JW, Floudas CS, Gulley JL, Gallia GL, Allen CT, London NR Jr.
Larkin RM, et al. Among authors: lopez dc.
J Transl Med. 2024 May 31;22(1):524. doi: 10.1186/s12967-024-05339-9.
J Transl Med. 2024.
PMID: 38822345
Free PMC article.